Meningococcal Infections Vaccine and Forecast - Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Meningococcal Infections Vaccine
1.2 Key Market Segments
1.2.1 Meningococcal Infections Vaccine Segment by Type
1.2.2 Meningococcal Infections Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Meningococcal Infections Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Meningococcal Infections Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Meningococcal Infections Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Meningococcal Infections Vaccine Market Competitive Landscape
3.1 Global Meningococcal Infections Vaccine Sales by Manufacturers (2019-2025)
3.2 Global Meningococcal Infections Vaccine Revenue Market Share by Manufacturers (2019-2025)
3.3 Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Meningococcal Infections Vaccine Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Meningococcal Infections Vaccine Sales Sites, Area Served, Product Type
3.6 Meningococcal Infections Vaccine Market Competitive Situation and Trends
3.6.1 Meningococcal Infections Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Meningococcal Infections Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Meningococcal Infections Vaccine Industry Chain Analysis
4.1 Meningococcal Infections Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Meningococcal Infections Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Meningococcal Infections Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Infections Vaccine Sales Market Share by Type (2019-2025)
6.3 Global Meningococcal Infections Vaccine Market Size Market Share by Type (2019-2025)
6.4 Global Meningococcal Infections Vaccine Price by Type (2019-2025)
7 Meningococcal Infections Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Infections Vaccine Market Sales by Application (2019-2025)
7.3 Global Meningococcal Infections Vaccine Market Size (M USD) by Application (2019-2025)
7.4 Global Meningococcal Infections Vaccine Sales Growth Rate by Application (2019-2025)
8 Meningococcal Infections Vaccine Market Consumption by Region
8.1 Global Meningococcal Infections Vaccine Sales by Region
8.1.1 Global Meningococcal Infections Vaccine Sales by Region
8.1.2 Global Meningococcal Infections Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Meningococcal Infections Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Meningococcal Infections Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Meningococcal Infections Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Meningococcal Infections Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Meningococcal Infections Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Meningococcal Infections Vaccine Market Production by Region
9.1 Global Production of Meningococcal Infections Vaccine by Region (2019-2025)
9.2 Global Meningococcal Infections Vaccine Revenue Market Share by Region (2019-2025)
9.3 Global Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Meningococcal Infections Vaccine Production
9.4.1 North America Meningococcal Infections Vaccine Production Growth Rate (2019-2025)
9.4.2 North America Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Meningococcal Infections Vaccine Production
9.5.1 Europe Meningococcal Infections Vaccine Production Growth Rate (2019-2025)
9.5.2 Europe Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Meningococcal Infections Vaccine Production (2019-2025)
9.6.1 Japan Meningococcal Infections Vaccine Production Growth Rate (2019-2025)
9.6.2 Japan Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Meningococcal Infections Vaccine Production (2019-2025)
9.7.1 China Meningococcal Infections Vaccine Production Growth Rate (2019-2025)
9.7.2 China Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Pfizer
10.1.1 Pfizer Meningococcal Infections Vaccine Basic Information
10.1.2 Pfizer Meningococcal Infections Vaccine Product Overview
10.1.3 Pfizer Meningococcal Infections Vaccine Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer Meningococcal Infections Vaccine SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Sinopharm
10.2.1 Sinopharm Meningococcal Infections Vaccine Basic Information
10.2.2 Sinopharm Meningococcal Infections Vaccine Product Overview
10.2.3 Sinopharm Meningococcal Infections Vaccine Product Market Performance
10.2.4 Sinopharm Business Overview
10.2.5 Sinopharm Meningococcal Infections Vaccine SWOT Analysis
10.2.6 Sinopharm Recent Developments
10.3 CanSino Biologics
10.3.1 CanSino Biologics Meningococcal Infections Vaccine Basic Information
10.3.2 CanSino Biologics Meningococcal Infections Vaccine Product Overview
10.3.3 CanSino Biologics Meningococcal Infections Vaccine Product Market Performance
10.3.4 CanSino Biologics Meningococcal Infections Vaccine SWOT Analysis
10.3.5 CanSino Biologics Business Overview
10.3.6 CanSino Biologics Recent Developments
10.4 Zhi Fei Biological
10.4.1 Zhi Fei Biological Meningococcal Infections Vaccine Basic Information
10.4.2 Zhi Fei Biological Meningococcal Infections Vaccine Product Overview
10.4.3 Zhi Fei Biological Meningococcal Infections Vaccine Product Market Performance
10.4.4 Zhi Fei Biological Business Overview
10.4.5 Zhi Fei Biological Recent Developments
11 Meningococcal Infections Vaccine Market Forecast by Region
11.1 Global Meningococcal Infections Vaccine Market Size Forecast
11.2 Global Meningococcal Infections Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Meningococcal Infections Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Meningococcal Infections Vaccine Market Size Forecast by Region
11.2.4 South America Meningococcal Infections Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Meningococcal Infections Vaccine by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Meningococcal Infections Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Meningococcal Infections Vaccine by Type (2025-2032)
12.1.2 Global Meningococcal Infections Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Meningococcal Infections Vaccine by Type (2025-2032)
12.2 Global Meningococcal Infections Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Meningococcal Infections Vaccine Sales (K Units) Forecast by Application
12.2.2 Global Meningococcal Infections Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Meningococcal Infections Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Meningococcal Infections Vaccine Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Meningococcal Infections Vaccine Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Meningococcal Infections Vaccine Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Meningococcal Infections Vaccine Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2022)
Table 10. Global Market Meningococcal Infections Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Meningococcal Infections Vaccine Sales Sites and Area Served
Table 12. Manufacturers Meningococcal Infections Vaccine Product Type
Table 13. Global Meningococcal Infections Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Meningococcal Infections Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Meningococcal Infections Vaccine Market Challenges
Table 22. Global Meningococcal Infections Vaccine Sales by Type (K Units)
Table 23. Global Meningococcal Infections Vaccine Market Size by Type (M USD)
Table 24. Global Meningococcal Infections Vaccine Sales (K Units) by Type (2019-2025)
Table 25. Global Meningococcal Infections Vaccine Sales Market Share by Type (2019-2025)
Table 26. Global Meningococcal Infections Vaccine Market Size (M USD) by Type (2019-2025)
Table 27. Global Meningococcal Infections Vaccine Market Size Share by Type (2019-2025)
Table 28. Global Meningococcal Infections Vaccine Price (USD/Unit) by Type (2019-2025)
Table 29. Global Meningococcal Infections Vaccine Sales (K Units) by Application
Table 30. Global Meningococcal Infections Vaccine Market Size by Application
Table 31. Global Meningococcal Infections Vaccine Sales by Application (2019-2025) & (K Units)
Table 32. Global Meningococcal Infections Vaccine Sales Market Share by Application (2019-2025)
Table 33. Global Meningococcal Infections Vaccine Sales by Application (2019-2025) & (M USD)
Table 34. Global Meningococcal Infections Vaccine Market Share by Application (2019-2025)
Table 35. Global Meningococcal Infections Vaccine Sales Growth Rate by Application (2019-2025)
Table 36. Global Meningococcal Infections Vaccine Sales by Region (2019-2025) & (K Units)
Table 37. Global Meningococcal Infections Vaccine Sales Market Share by Region (2019-2025)
Table 38. North America Meningococcal Infections Vaccine Sales by Country (2019-2025) & (K Units)
Table 39. Europe Meningococcal Infections Vaccine Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Meningococcal Infections Vaccine Sales by Region (2019-2025) & (K Units)
Table 41. South America Meningococcal Infections Vaccine Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Meningococcal Infections Vaccine Sales by Region (2019-2025) & (K Units)
Table 43. Global Meningococcal Infections Vaccine Production (K Units) by Region (2019-2025)
Table 44. Global Meningococcal Infections Vaccine Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Meningococcal Infections Vaccine Revenue Market Share by Region (2019-2025)
Table 46. Global Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Pfizer Meningococcal Infections Vaccine Basic Information
Table 52. Pfizer Meningococcal Infections Vaccine Product Overview
Table 53. Pfizer Meningococcal Infections Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Pfizer Business Overview
Table 55. Pfizer Meningococcal Infections Vaccine SWOT Analysis
Table 56. Pfizer Recent Developments
Table 57. Sinopharm Meningococcal Infections Vaccine Basic Information
Table 58. Sinopharm Meningococcal Infections Vaccine Product Overview
Table 59. Sinopharm Meningococcal Infections Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Sinopharm Business Overview
Table 61. Sinopharm Meningococcal Infections Vaccine SWOT Analysis
Table 62. Sinopharm Recent Developments
Table 63. CanSino Biologics Meningococcal Infections Vaccine Basic Information
Table 64. CanSino Biologics Meningococcal Infections Vaccine Product Overview
Table 65. CanSino Biologics Meningococcal Infections Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. CanSino Biologics Meningococcal Infections Vaccine SWOT Analysis
Table 67. CanSino Biologics Business Overview
Table 68. CanSino Biologics Recent Developments
Table 69. Zhi Fei Biological Meningococcal Infections Vaccine Basic Information
Table 70. Zhi Fei Biological Meningococcal Infections Vaccine Product Overview
Table 71. Zhi Fei Biological Meningococcal Infections Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Zhi Fei Biological Business Overview
Table 73. Zhi Fei Biological Recent Developments
Table 74. Global Meningococcal Infections Vaccine Sales Forecast by Region (2025-2032) & (K Units)
Table 75. Global Meningococcal Infections Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 76. North America Meningococcal Infections Vaccine Sales Forecast by Country (2025-2032) & (K Units)
Table 77. North America Meningococcal Infections Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 78. Europe Meningococcal Infections Vaccine Sales Forecast by Country (2025-2032) & (K Units)
Table 79. Europe Meningococcal Infections Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 80. Asia Pacific Meningococcal Infections Vaccine Sales Forecast by Region (2025-2032) & (K Units)
Table 81. Asia Pacific Meningococcal Infections Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 82. South America Meningococcal Infections Vaccine Sales Forecast by Country (2025-2032) & (K Units)
Table 83. South America Meningococcal Infections Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 84. Middle East and Africa Meningococcal Infections Vaccine Consumption Forecast by Country (2025-2032) & (Units)
Table 85. Middle East and Africa Meningococcal Infections Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 86. Global Meningococcal Infections Vaccine Sales Forecast by Type (2025-2032) & (K Units)
Table 87. Global Meningococcal Infections Vaccine Market Size Forecast by Type (2025-2032) & (M USD)
Table 88. Global Meningococcal Infections Vaccine Price Forecast by Type (2025-2032) & (USD/Unit)
Table 89. Global Meningococcal Infections Vaccine Sales (K Units) Forecast by Application (2025-2032)
Table 90. Global Meningococcal Infections Vaccine Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Meningococcal Infections Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningococcal Infections Vaccine Market Size (M USD), 2019-2032
Figure 5. Global Meningococcal Infections Vaccine Market Size (M USD) (2019-2032)
Figure 6. Global Meningococcal Infections Vaccine Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningococcal Infections Vaccine Market Size by Country (M USD)
Figure 11. Meningococcal Infections Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Meningococcal Infections Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Meningococcal Infections Vaccine Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Meningococcal Infections Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Meningococcal Infections Vaccine Market Share by Type
Figure 18. Sales Market Share of Meningococcal Infections Vaccine by Type (2019-2025)
Figure 19. Sales Market Share of Meningococcal Infections Vaccine by Type in 2023
Figure 20. Market Size Share of Meningococcal Infections Vaccine by Type (2019-2025)
Figure 21. Market Size Market Share of Meningococcal Infections Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Meningococcal Infections Vaccine Market Share by Application
Figure 24. Global Meningococcal Infections Vaccine Sales Market Share by Application (2019-2025)
Figure 25. Global Meningococcal Infections Vaccine Sales Market Share by Application in 2023
Figure 26. Global Meningococcal Infections Vaccine Market Share by Application (2019-2025)
Figure 27. Global Meningococcal Infections Vaccine Market Share by Application in 2023
Figure 28. Global Meningococcal Infections Vaccine Sales Growth Rate by Application (2019-2025)
Figure 29. Global Meningococcal Infections Vaccine Sales Market Share by Region (2019-2025)
Figure 30. North America Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Meningococcal Infections Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Meningococcal Infections Vaccine Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Meningococcal Infections Vaccine Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Meningococcal Infections Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Meningococcal Infections Vaccine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Meningococcal Infections Vaccine Sales Market Share by Region in 2023
Figure 44. China Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Meningococcal Infections Vaccine Sales and Growth Rate (K Units)
Figure 50. South America Meningococcal Infections Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Meningococcal Infections Vaccine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Meningococcal Infections Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Meningococcal Infections Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Meningococcal Infections Vaccine Production Market Share by Region (2019-2025)
Figure 62. North America Meningococcal Infections Vaccine Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Meningococcal Infections Vaccine Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Meningococcal Infections Vaccine Production (K Units) Growth Rate (2019-2025)
Figure 65. China Meningococcal Infections Vaccine Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Meningococcal Infections Vaccine Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Meningococcal Infections Vaccine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Meningococcal Infections Vaccine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Meningococcal Infections Vaccine Market Share Forecast by Type (2025-2032)
Figure 70. Global Meningococcal Infections Vaccine Sales Forecast by Application (2025-2032)
Figure 71. Global Meningococcal Infections Vaccine Market Share Forecast by Application (2025-2032)
Industry Market Size
